Clinical Trial Update: Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing safety, tolerance, and pharmacokinetics of raltegravir-containing ART in infants and children with HIV and tuberculosis; study complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Tuberculosis

Drugs mentioned

• raltegravir-containing antiretroviral therapy (raltegravir)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Tuberculosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-12-21